Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Thomas Coates, MD
Researcher Section Head, Hematology
Children's Hospital Los Angeles
4650 Sunset Blvd
Hematology/Oncology, #54
Los Angeles, California, United States
Dr. Thomas is currently working as section head of hematology, as attending physician in hematology oncology and bone marrow transplantation section and one of investigator in hematology-oncology at Children’s Hospital Los Angeles. He is also associated with Keck School of Medicine of USC as professor of pediatrics. He is a clinical specialist in hematology and red blood cell disorders while his area of research broadly covers cancer and blood diseases. He primarily works in two areas of basic and translational research: 1) the role of inflammation in the genesis of vascular disease in sickle cell disease; 2) the detection and management of transfusion related iron overload. His research employs various engineering-intensive methodologies (MRI, laser Doppler flow, digital image analysis, signal processing) to explore the basic mechanisms of sickle cell disease and to measure the effect of various treatment modalities.
Representative Publications:
Contrasting resting-state fMRI abnormalities from sickle and non-sickle anemia
The effect of hypnosis on pain and peripheral blood flow in sickle-cell disease: a pilot study
Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease
Determinants of resting cerebral blood flow in sickle cell disease
Related Content
-
Jerlym S. Porter, PhD, MPHJerlym S. Porter is an Associate Member ...
-
James R Eckman, MDJames Eckman, MD, is emeritus professor ...
-
Four Solutions for Sickle Cell Disease SupportWhen Precious Lee was a year old, she be...
-
Roald Dahl’s Marvellous Children’s Charity “Everyone’s Business” campaignhttps://www.youtube.com/watch?v=VqdP3Sxa...
-
Oxygen’s surprisingly complex journey through your body – Enda Butlerhttps://www.youtube.com/watch?v=GVU_zANt...
-
GlycoMimetics Announces Pricing of Public Offering of Common StockGlycoMimetics, Inc. (NASDAQ: GLYC), a cl...
-
Pediatric prescriber pratices of hyrdoxyurea in sickle cell diseaseHydroxyurea (HU) has been shown to be ef...
+myBinder